Literature DB >> 11795928

Pre-operative localization of parathyroid adenomas: a comparison of power and colour Doppler ultrasonography with nuclear medicine scintigraphy.

J D Scheiner1, D E Dupuy, J M Monchik, R B Noto, J J Cronan.   

Abstract

AIM: To compare power and colour Doppler ultrasonography (US) with nuclear medicine scintigraphy (NM) in the preoperative localization of parathyroid adenomas in patients with primary hyperparathyroidism (PHPT).
MATERIALS AND METHODS: Thirty-one patients with biochemical evidence of PHPT underwent pre-operative US and NM for parathyroid adenoma localization. Both studies were interpreted independently without prior knowledge of the other study's findings. All patients had surgical removal of the parathyroid adenoma utilizing standard neck exploration or minimally invasive unilateral surgical techniques with rapid serum assay of circulating parathyroid hormone levels.
RESULTS: All patients had single parathyroid adenomas at surgery. Prospective sensitivities for US, NM and both studies combined were 65%, 68%, and 74%, respectively, with a positive predictive value of 100% each. The adenoma was localized by only one imaging modality in 16% of cases.
CONCLUSIONS: US and NM provide complementary roles in the pre-operative localization of parathyroid adenomas in patients with PHPT.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11795928     DOI: 10.1053/crad.2001.0793

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  20 in total

Review 1.  How to localize parathyroid tumors in primary hyperparathyroidism?

Authors:  T Uruno; E Kebebew
Journal:  J Endocrinol Invest       Date:  2006-10       Impact factor: 4.256

2.  Three-dimensional ultrasonography before minimally invasive focused parathyroidectomy: the importance of coronal images.

Authors:  Rika Miyabe
Journal:  Surg Today       Date:  2009-02-07       Impact factor: 2.549

Review 3.  Imaging for primary hyperparathyroidism--an evidence-based analysis.

Authors:  Radu Mihai; Dietmar Simon; Per Hellman
Journal:  Langenbecks Arch Surg       Date:  2009-07-10       Impact factor: 3.445

4.  Video-assisted bilateral neck exploration in patients with primary hyperparathyroidism and failed localization studies.

Authors:  Pier F Alesina; Reyaz M Singaporewalla; Martin K Walz
Journal:  World J Surg       Date:  2010-10       Impact factor: 3.352

5.  Imaging features of primary hyperparathyroidism.

Authors:  Tsella Lachungpa; Radha Sarawagi; Sunitha Vellathussery Chakkalakkoombil; Annitha Elavarasi Jayamohan
Journal:  BMJ Case Rep       Date:  2014-03-10

6.  Role of ultrasonography in the management of patients with primary hyperparathyroidism: retrospective comparison with technetium-99m sestamibi scintigraphy.

Authors:  Giovanni Mariano Vitetta; Pierluigi Neri; Andrea Chiecchio; Alessandro Carriero; Stefano Cirillo; Annalisa Balbo Mussetto; Alessandra Codegone
Journal:  J Ultrasound       Date:  2014-01-31

7.  Primary hyperparathyroidism: an analysis of failure of parathyroidectomy.

Authors:  A Bagul; H P Patel; D Chadwick; B J Harrison; S P Balasubramanian
Journal:  World J Surg       Date:  2014-03       Impact factor: 3.352

Review 8.  Bilateral neck exploration in primary hyperparathyroidism--when is it selected and how is it performed?

Authors:  Jacob Moalem; Marlon Guerrero; Electron Kebebew
Journal:  World J Surg       Date:  2009-11       Impact factor: 3.352

9.  Actual role of color-doppler high-resolution neck ultrasonography in primary hyperparathyroidism: a clinical review and an observational study with a comparison of 99mTc-sestamibi parathyroid scintigraphy.

Authors:  Giovanni Mariano Vitetta; Alberto Ravera; Giovanni Mensa; Luca Fuso; Pierluigi Neri; Alessandro Carriero; Stefano Cirillo
Journal:  J Ultrasound       Date:  2018-10-24

10.  Pre-operative localisation of hyperfunctional parathyroid tissue with 11C-methionine PET.

Authors:  D Otto; A R Boerner; M Hofmann; T Brunkhorst; G J Meyer; T Petrich; G F Scheumann; W H Knapp
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-07-29       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.